Geriatric Nursing
Volume 27, Issue 2 , Pages 118-129 , March 2006

Herbal, Prescribed, and Over-the-Counter Drug Use in Older Women: Prevalence of Drug Interactions

References 

  1. Kelly JP , Kaufman DW , Kelley K , et al.   Recent trends in use of herbal and other natural products . Arch Int Med . 2005;165:281–286
  2. Bruno JJ , Ellis JJ . Herbal use among U.S. elderly (2002 National Health Interview Survey) . Ann Pharmacother . 2005;39:643–648
  3. Eskin SB . Dietary supplements and older consumers . Data Digest . 2001;66:1–8 AARP Public Policy Institute: Washington, DC
  4. Yoon SL , Horne CH . Herbal products and conventional medicines used by community-residing older women . J Adv Nurs . 2001;33:51–59
  5. Yoon SL , Horne CH , Adams C . Herbal product use by African American older women . Clin Nurs Res . 2004;13:271–288
  6. Eisenberg DM , Davis RB , Ettner SL , et al.   Trends in alternative medicine use in the United States, 1990-1997 (results of a follow-up national survey) . JAMA . 1998;280:1569–1575
  7. Solberg LI , Hurley JS , Roberts MH , et al.   Measuring patient safety in ambulatory care (potential for identifying medical group drug-drug interaction rates using claims data) . Am J Manag Care . 2004;10:753–759
  8. Kaufman DW , Kelly JP , Rosenberg L , et al.   Recent patterns of medication use in the ambulatory adult population of the United States (the Slone survey) . JAMA . 2002;287:337–344
  9. Turnheim K . Drug dosage in the elderly (is it rational?) . Drugs Aging . 1998;13:357–379
  10. Turnheim K . Drug therapy in the elderly . Exp Gerontol . 2004;39:1731–1738
  11. Wolfe MM , Lichtenstein DR , Singh G . Gastrointestinal toxicity of nonsteroidal drugs . N Engl J Med . 1999;340:1888–1899
  12. Johnson AG . NSAIDs and increased blood pressure (What is the clinical significance?) . Drug Safety . 1997;17:277–289
  13. Peng CC , Glassman PA , Marks IR , et al.   Retrospective drug utilization review (incidence of clinically relevant potential drug-drug interactions in a large ambulatory populations) . J Manag Care Pharm . 2003;9:513–522
  14. Yoon SL . Use of herbal products, prescribed medicines and non-prescribed medicines by community-dwelling older women . University of Florida: Doctoral dissertation; 1999; Diss Abstracts Int 60:W4Y591u1999.
  15. Vaes LP , Chyka PA . Interactions of warfarin with garlic, ginger, ginkgo, or ginseng (nature of the evidence.Review) . Ann Pharmacother . 2000;34:1478–1482
  16. U.S. Department of Health and Human Services, Food and Drug Administration, 21 CFR Part 343 (docket no. 77N—094A). . Internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final rule for professional labeling of aspirin, buffered aspirin, and aspirin in combination with antacid drug products . 2005; www.fda.gov/ohrms/dockets/ac/02 /briefing/3882b1_01_F-Professional%20Labeling.pdf. Cited October 6,
  17. Murphey LM , Hood EH . Bosentan and warfarin interaction . Ann Pharmacother . 2003;37:1028–1031
  18. Gugler R , Allgayer H . Effects of antacids on the clinical pharmacokinetics of drugs. An update . Clin Pharmacokinet . 1990;18:210–219
  19. Singh N , Weisler SL , Hershman JM . The acute effect of calcium carbonate on the intestinal absorption of levothyroxine . Thyroid . 2001;11:967–971
  20. PDR Electronic Library . Thomson Micromedex; 2002-2006 . 2005; www.thomsonhc.com/pdrel/librarian Cited October 6,
  21. Hansten PD , Horn JR . Cytochrome P450 enzymes and drug interactions, table of cytochrome P450 substrates, inhibitors, inducers and P-glycoprotein and footnotes . In: The top 100 drug interactions—a guide to patient management . Edmonds, WA: H&H publications; 2005;p. 157–170
  22. Henderson L , Yue QY , Bergquist C , et al.   St John’s wort (Hypericum perforatum) (drug interactions and clinical outcomes) . Br J Clin Pharmacol . 2002;54:349–356
  23. U.S. Food and Drug Administration. Draft guidance for industry labeling for noncontraceptive estrogen drug products. Document No. 5670. Division of Dockets Management (HFA-305). Rockville, MD: Food and Drug Administration.Available atwww.fda.gov/cder/guidance/5670dft.pdfAccessed October 6, 2005
  24. Sperber AD , Liel Y . Evidence for interference with the intestinal absorption of levothyroxine sodium by aluminum hydroxide . Arch Int Med . 1992;152:183–184
  25. Yue QY , Bergquist C , Gerden B . Seven cases of decreased effect of warfarin during concomitant treatment with St. John’s wort (correspondence) . Lancet . 2000;355:576–577
  26. Ang-Lee MK , Moss J , Yuan CS . Herbal medicines and perioperative care . JAMA . 2001;286:208–216
  27. Kurtovic J , Riordan SM . Paracetamol-induced hepatotoxicity at recommended dosage . J Intern Med . 2003;253:240–243
  28. Boesgaard S , Nielsen-Kudsk JE , Laursen JB , Aldershvile J . Thiols and nitrates (reevaluation of the thiol depletion theory of nitrate tolerance) . Am J Cardiol . 1998;81:21A–29A
  29. Package insert. Macrodantin (nitrofurantoin macrocrystals). Cincinnati, OH: Proctor & Gamble Pharmaceuticals.
  30. Naggar VF , Khalil SA . Effect of magnesium trisilicate on nitrofurantoin absorption . Clin Pharmacol Ther . 1979;25:857–863
  31. Roth T , Roehrs TA . A review of the safety profiles of benzodiazepine hypnotics . J Clin Psychiatry . 1991;52:38–41
  32. Ariga T , Oshiba S , Tamada T . Platelet aggregation inhibitor in garlic . Lancet . 1981;1:150–151
  33. Nurtjahja-Tjendraputra E , Ammit AJ , Roufogalis BD , et al.   Effective anti-platelet and COX-1 enzyme inhibitors from pungent constituents of ginger . Thromb Res . 2003;111:259–265
  34. Frishman WH . Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema . Am J Cardiol . 2002;89:18D–25D
  35. The sixth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. National Institute of Health publication No. 99-4080 . 1997;1–64
  36. Package insert. Florinef Acetate (fludrocortisone acetate). Bristol, TN: Monarch Pharmaceuticals.
  37. Gabriel SE , Jaakkimainen L , Bombardier C . Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs . Ann Intern Med . 1991;115:787–796
  38. Burke A , Smyth EM , FitzGerald GA . Analgesic-antipyretic agents (pharmacotherapy of gout) . In:  Brunton LL ,  Lazo JS ,  Parker KL editor. Goodman and Gilman’s the pharmacological basis of therapeutics . 11th ed.. New York: McGraw Hill; 2006;p. 671–715
  39. Dalton SO , Johansen C , Mellemkjaer L , et al.   Use of selective serotonin reuptake inhibitors and the risk of upper gastrointestinal tract bleeding (a population-based cohort study) . Arch Intern Med . 2003;163:59–64
  40. Fored CM , Ejerblad E , Lindblad P , et al.   Acetaminophen, aspirin, and chronic renal failure . N Engl J Med . 2001;345:1801–1808
  41. Miners JO . Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid . Clin Pharmacokinet . 1989;17:327–344
  42. Lamant V , Mauco G , Braquet P , et al.   Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba . Bio Pharmacol . 1987;36:2749–2752
  43. Teng CM , Kuo SC , Ko FN , et al.   Antiplatelet actions of panaxynol and ginsenosides isolated from ginseng . Biochem Biophys Acta . 1989;990:315–320
  44. Smith M , Lin KM , Zheng YP . An open trial of nifedipine-herb interactions (nifedipine with St. John’s wort, ginseng, or Ginkgo biloba) . [abstract]. Clin Pharmacol Ther . 2001;69:P86
  45. Sheela CG , Kumud K , Augusti KT . Anti-diabetic effects of onion and garlic sulfoxide amino acids in rats . Planta Med . 1995;61:356–357
  46. Package insert. Deltasone (prednisone). Kalamazoo, MI: Pharmacia & Upjohn Co.
  47. Welch MJ , Meltzer EO , Simons FE . H1-antihistamines and the central nervous system . Clin Allergy Immunol . 2002;17:337–388
  48. Dordoni B , Wilson RA , Thompson RPH , et al.   Reduction of absorption of paracetamol by activated charcoal and cholestyramine (a possible therapeutic measure) . BMJ . 1973;3:86–87
  49. Seixas FA . Alcohol and its drug interactions . Ann Intern Med . 1975;83:86–92
  50. Soll AH  Practice Parameters Committee of the American College of Gastroenterology . Medical treatment of peptic ulcer disease (practice guidelines) . JAMA . 1996;275:622–629
  51. Package insert. Antivert (meclizine). New York: Pfizer.
  52. Hoffman BB , Lefkowitz RJ . Atropine, scopolamine, and related antimuscarinic drugs . In:  Gilman AG ,  Rall TW ,  Nies AS ,  Taylor P editor. Goodman and Gilman’s pharmacological basis of therapeutics . 8th ed.. New York: Pergamon Press; 1990;p. 150–161
  53. Catella-Lason F , Reilly MP , Kapoor SC , et al.   Cyclooxygenase inhibitors and the antiplatelet effects of aspirin . N Engl J Med . 2001;345:1809–1817
  54. Taha AS , Angerson WA , Knill-Jones RP , et al.   Upper gastrointestinal haemorrhage associated with low-dose aspirin and anti-thrombotic drugs—a 6-year analysis and comparison with non-steroidal anti-inflammatory drugs . Aliment Pharmacol Ther . 2005;22:285–289
  55. Tarone RE , Blot WJ , McLaughlin JK . Nonselective nonaspirin nonsteroidal anti-inflammatory drugs and gastrointestinal bleeding (relative and absolute risk estimates from recent epidemiologic studies) . Am J Ther . 2004;11:17–25
  56. Stockl K , Cyprien L , Chang EY . Gastrointestinal bleeding rates among managed care patients newly started on cox-2 inhibitors or nonselective NSAIDs . J Manag Care Pharm . 2005;11:550–558
  57. Lanas A . Gastrointestinal injury from NSAID therapy (how to reduce the risk of complications) . Postgrad Med . 2005;117(6):23–31
  58. Kimmey MB , Lanas A . Review article (appropriate use of proton pump inhibitors with traditional nonsteroidal anti-inflammatory drugs and COX-2 selective inhibitors) . Aliment Pharmacol Ther . 2004;19:60–65
  59. Gora M , Seth S , Bay W , et al.   Milk-alkali syndrome associated with use of chlorothiazide and calcium carbonate . Clin Pharm . 1989;8:227–229

PII: S0197-4572(06)00074-7

doi: 10.1016/j.gerinurse.2006.02.014

Geriatric Nursing
Volume 27, Issue 2 , Pages 118-129 , March 2006

Article Tools